| NUGAX | RWIAX | NUGAX / RWIAX | |
| Total Expense Ratio | 1.15 | 1.51 | 76% |
| Annual Report Gross Expense Ratio | 1.91 | 1.51 | 126% |
| Fund Existence | 14 years | 24 years | - |
| Gain YTD | 3.902 | 15.218 | 26% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 2500 | 250 | 1,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 16.5M | 160B | 0% |
| Annual Yield % from dividends | 1.33 | 0.73 | 181% |
| Returns for 1 year | 3.11 | 20.85 | 15% |
| Returns for 3 years | 23.13 | 49.70 | 47% |
| Returns for 5 years | 17.19 | 31.19 | 55% |
| Returns for 10 years | 59.12 | 102.34 | 58% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| CSHZX | 13.70 | 0.15 | +1.11% |
| NYLI Cushing® MLP Premier Class I | |||
| FSMAX | 116.33 | N/A | N/A |
| Fidelity Extended Market Index | |||
| ACIZX | 66.86 | N/A | N/A |
| Alger Capital Appreciation Instl Z-2 | |||
| BIPIX | 80.88 | N/A | N/A |
| ProFunds Biotechnology UltraSector Inv | |||
| TASVX | 22.54 | N/A | N/A |
| PGIM Quant Solutions Small-Cap Val Z | |||